| (X)                                                                                                                                         | Annual      Report under Section 13 or 15(d) of the Securities Exchange Act of 1934      for the fiscal year ended November 30, 2008. |
|---------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|
|                                                                                                                                        |                                                                                                                                  |
| Commission      File Number:  001-10221                                                                                           |
|                                                                                                                                        |                                                                                                                                  |
| MultiCell      Technologies, Inc.(Name      of small business issuer in its charter)                                                        |
|                                                                                                                                        |                                                                                                                                  |
| DELAWARE(State      or other jurisdiction ofincorporation      or organization)                                                             | 52-1412493(IRS      Employer Identification No.)                                                                                      |
|                                                                                                                                        |                                                                                                                                  |
| 68      Cumberland Street, Suite 301Woonsocket,      RI 02895401-762-0045(Address      and telephone number of principal executive offices) |
|                                                                                                                                        |                                                                                                                                  |
| Securities      registered under Section 12(b) of the Exchange Act:None                                                                     |
|                                                                                                                                        |                                                                                                                                  |
| Securities      registered pursuant to Section 12(g) of the Act:                                                                            |
|   Common Stock, $0.01 par value      per share                                                                               |

----

|                  |                         | PAGE   |
|-----------------------|------------------------------|--------|
| EXPLANATORY      NOTE |                         | 1      |
| PART II               |                         |   |
| Item      8A(T).      | CONTROLS      AND PROCEDURES | 1      |
| PART III              |                         |   |
| Item      13.         | EXHIBITS                     | 2      |
| SIGNATURES            | 3                            |
| EXHIBIT      INDEX    | 4                            |
|                  |                         |

----

| 1.   | Entity-Level      Controls: We did not maintain effective entity-level controls as defined      by the framework issued by COSO. Specifically, we did not effectively      segregate certain accounting duties due to the small size of our      accounting staff, and maintain a sufficient number of adequately trained      personnel necessary to anticipate and identify risks critical to financial      reporting. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

| 2.   | Information      Technology: We did not maintain effective controls over the segregation of      duties and access to financial reporting systems. Specifically, key      financial reporting systems were not appropriately configured to ensure      that certain transactions were properly processed with segregated duties      among personnel and to ensure that unauthorized individuals did not have      access to add or change key financialdata. |
|----------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|   | MULTICELL      TECHNOLOGIES, INC. (Registrant)  |                                                                                                     |
|--------|------------------------------------------------------|----------------------------------------------------------------------------------------------------------|
|   |                                                 |                                                                                                     |   |
|   | By:                                                  | /s/ W.      Gerald Newmin                                                                           |   |
|   |                                                 | W.      Gerald NewminChairman,      CEO, CFO, President, Treasurer andSecretaryDated      August 7, 2009 |   |

| Signature                                     | Title                                                       | Date                |
|-----------------------------------------------|-------------------------------------------------------------|---------------------|
|                                          |                                                        |                |
| /s/W. Gerald      NewminW.      Gerald Newmin | Chairman      ,CEO, CFO, President, Treasurer and Secretary | August      7, 2009 |

----

EXHIBIT INDEX

| Exhibit      No.   |   | Description      of Exhibit                                                                                                                                                                                                                                                                                                                |
|--------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 2.1      (1)  |   | Asset      Contribution Agreement dated September 7, 2005 by and among Multicell      Technologies, Inc., Astral Therapeutics, Inc., Alliance Pharmaceutical      Corp., and Astral, Inc.                                                                                                                                                  |
| 3.1      (2)       |   | Certificate      of Incorporation, as filed on April 28, 1970.                                                                                                                                                                                                                                                                             |
| 3.2      (2)       |   | Certificate      of Amendment, as filed on October 27, 1986.                                                                                                                                                                                                                                                                               |
| 3.3      (2)       |   | Certificate      of Amendment, as filed on August 24, 1989.                                                                                                                                                                                                                                                                                |
| 3.4      (2)       |   | Certificate      of Amendment, as filed on July 31, 1991.                                                                                                                                                                                                                                                                                  |
| 3.5      (2)       |   | Certificate      of Amendment, as filed on August 14, 1991.                                                                                                                                                                                                                                                                                |
| 3.6      (2)       |   | Certificate      of Amendment, as filed on June 13, 2000.                                                                                                                                                                                                                                                                                  |
| 3.7      (2)       |   | Certificate      of Amendment, as filed May 18, 2005.                                                                                                                                                                                                                                                                                      |
| 3.8      (2)       |   | Certificate      of Correction, as filed June 2, 2005.                                                                                                                                                                                                                                                                                     |
| 3.9      (2)       |   | Bylaws,      as amended May 18, 2005.                                                                                                                                                                                                                                                                                                      |
| 3.10      (2)      |   | Specimen      Stock Certificate.                                                                                                                                                                                                                                                                                                           |
| 4.1      (3)  |   | Certificate      of Designations of Preferences and Rights of Series I Convertible      Preferred Stock, as filed on July 13, 2004.                                                                                                                                                                                                        |
| 4.2      (4)       |   | Certificate      of Designation of Series B Convertible Preferred Stock, as filed on July      14, 2006.                                                                                                                                                                                                                                   |
| 4.3      (5)       |   | Debenture      Purchase Agreement between Multicell Technologies, Inc. and La Jolla Cove      Investors, Inc. dated February 28, 2007                                                                                                                                                                                                      |
| 4.4      (5)       |   | Registration      Rights Agreement between Multicell Technologies, Inc. and La Jolla Cove      Investors, Inc. dated February 28, 2007                                                                                                                                                                                                     |
| 4.5      (5)       |   | Stock      Pledge Agreement dated February 28, 2007                                                                                                                                                                                                                                                                                   |
| 4.6      (5)       |   | 7 3⁄4      % Convertible Debenture for $1,000,000 issued by Multicell Technologies,      Inc. to La Jolla Cove Investors, Inc.                                                                                                                                                                                                          |
| 4.7      (5)       |   | Escrow      Letter dated February 28, 2007 from La Jolla Cove Investors,      Inc.                                                                                                                                                                                                                                                    |
| 4.8      (5)       |   | Letter      dated February 28, 2007 from La Jolla Cove Investors, Inc.                                                                                                                                                                                                                                                                |
| 4.9      (5)       |   | Securities      Purchase Agreement between Multicell Technologies, Inc. and La Jolla Cove      Investors, Inc. dated February 28, 2007                                                                                                                                                                                                     |
| 4.10      (5)      |   | 4 3⁄4      % Convertible Debenture for $100,000 issued by Multicell Technologies,      Inc. to La Jolla Cove Investors, Inc.                                                                                                                                                                                                            |
| 4.11      (5)      |   | Warrant      to Purchase Common Stock dated February 28, 2007                                                                                                                                                                                                                                                                         |
| 4.12      (5)      |   | Letter      dated February 28, 2007 to Multicell Technologies, Inc. from La Jolla Cove      Investors, Inc.                                                                                                                                                                                                                           |
| 4.13      (6)      |   | Warrant      for the purchase of 1,572,327 Shares of Common Stock of Multicell      Technologies, Inc. issued to and Fusion Capital Fund II, LLC dated May 3,      2006.                                                                                                                                                                   |
| 4.14      (7)      |   | Amended      and Restated Registration Rights Agreement, dated as of October 5, 2006,      by and between Multicell Technologies, Inc. and Fusion Capital Fund II,      LLC.                                                                                                                                                               |
| 4.15      (8)      |   | Form      of Warrant to Purchase Common Stock (Cashless Exercise) dated July 14,      2006 issued by Multicell Technologies, Inc. to Monarch Pointe Fund, Ltd.,      Mercator Momentum Fund III, L.P., Asset Managers International Ltd. and      Pentagon Special Purpose Fund Ltd.                                                       |
| 4.16      (8)      |   | Form      of Warrant to Purchase Common Stock (Cash Exercise), dated July 14, 2006,      issued by Multicell Technologies, Inc. to Monarch Pointe Fund, Ltd.,      Mercator Momentum Fund III, L.P., Asset Managers International Ltd. and      Pentagon Special Purpose Fund Ltd.                                                         |
| 4.17      (8)      |   | Form      of Registration Rights Agreement dated July 14, 2006 by and between      Multicell Technologies, Inc. and Monarch Pointe Fund, Ltd., Mercator      Momentum Fund III, L.P., Asset Managers International Ltd. and Pentagon      Special Purpose Fund Ltd.                                                                        |
| 4.18      (8)      |   | Form      of Shares of Series B Convertible Preferred Stock and Common Stock      Warrants Subscription Agreement dated July 14, 2006 by and between      Multicell Technologies, Inc. and Monarch Pointe Fund, Ltd., Mercator      Momentum Fund III, L.P., Asset Managers International Ltd. and Pentagon      Special Purpose Fund Ltd. |
| 4.19      (9)      |   | Amended      and Restated Warrant to Purchase Common Stock issued to Anthony Cataldo      dated July 25, 2006.                                                                                                                                                                                                                             |

----

| 4.20      (10)                                |   | Form      of Warrant to Purchase Common Stock dated February 1, 2006 issued by the      Company to Trilogy Capital Partners, Inc.                                                                      |
|-----------------------------------------------|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.21      (11)                                |   | Mutual      Termination Agreement between Multicell Technologies, Inc. and Fusion      Capital Fund II, LLC, dated as of July 18, 2007.                                                                |
| 10.1      (12)                                |   | Letter      Agreement between Amarin Neuroscience Limited and the Company dated      October 26, 2006.                                                                                                 |
| 10.2      (13)                                |   | Letter      Agreement between Amarin Neuroscience Limited and the Company dated June      28, 2006.                                                                                                    |
| 10.3      (14)                                |   | Worldwide      Exclusive License Agreement dated as of December 31, 2005 between      Multicell Technologies, Inc. and Amarin Neuroscience Limited dated      December 31, 2005.                       |
| 10.4      (15)                                |   | License      Agreement between Eisai Co., Ltd. and the Company dated April 20,      2007.                                                                                                              |
| 10.5      (16)                                |   | License      Agreement between Corning Incorporated and the Company dated October 9,      2007.                                                                                                        |
| 31.1*                                         |   | Certification      of the Chief Executive Officer and Chief Financial Officer pursuant to      Section 302(a) of the Sarbanes-Oxley Act of 2002.                                                       |
| 32.1*                                         |   | Certification      of Chief Executive Officer and the Chief Financial Officer pursuant to 18      U.S.C. Section 1350, as adopted pursuant to Section 906 of the      Sarbanes-Oxley Act of 2002. |
| *    Filed      herewith. |

----